Top Influencers: 20 UK President & CEO’s To Follow in 2022

Emmanuel joined GE Healthcare in April 2008, following its acquisition of Whatman International Plc. Since 2008, Emmanuel has held various positions in GE Healthcare Life Sciences. Working both in the UK and in the US, he managed the North America BioProcess business. In January 2012, Emmanuel took charge of the Commercial part of the then Life Sciences business, across EMEA, later expanding his role to include global commercial leadership of BioProcess. In January 2016, Emmanuel was name General Manager of the Core Imaging business which he held until he was named President and CEO of Life Sciences In July 2017. Emmanuel first entered the biopharma industry in Japan, joining Ostuka Pharmaceutical International Ltd as a Medical Representative in Tokyo. After five years in Ostuka in various roles, Emmanuel joined Abbott Japan, occupying positions such as Marketing Director Diagnostic Division and Commercial Director Diabetes Care Division. After 10 years in Japan, Emmanuel moved to the UK as Vice President Sales & Marketing Europe for Whatman International Plc. Learn more about Emmanuel Ligner on Crunchbase…

Gregory Case is President and Chief Executive Officer of Aon plc, the leading global provider of risk management solutions, insurance and reinsurance brokerage and Human Resource solutions. Greg is also a Member of the Board of Directors AT Aon plc. As Chief Executive Officer, Greg directs the efforts of more than 72,000 colleagues in more than 120 countries. Greg has focused the organization on a three-part strategy for building Aon centered around providing distinctive value for clients, attracting the best talent and achieving operational excellence. Greg has nearly two decades of experience in the insurance and financial services industries. Before joining Aon, Greg served on the governing Shareholders’ Council at McKinsey & Company, a leading international management consultant, and led their Global Insurance and Financial Services Practice. Prior to McKinsey, Greg worked for the investment banking firm of Piper, Jaffray and Hopwood and at the Federal Reserve Bank. Greg holds an MBA from Harvard Business School and graduated summa cum laude from Kansas State University. Greg serves on the boards of Discover Financial Services, Ann & Robert H. Lurie Children’s Hospital, Field Museum of Natural History, CEO’s Against Cancer and St. John’s University School of Risk Management. In 2014, Greg was named by the Harvard Business Review as one of the top 100 best performing CEOs in the world. Learn more about Gregory Case on Crunchbase…

Richard is the founder and CEO of moo.com, one of the world’s fastest-growing print businesses. Launched in late 2006, MOO is focussed on disrupting the trillion dollar print industry, with its unique approach to design, technology and operations. This has allowed it to sustain industry-leading NPS, gross margin and top-line growth for a business of its size. To date, MOO has served millions of customers in nearly 200 countries and employs over 400 people across 6 locations in the UK and USA. Before founding MOO, Richard worked for the design company Imagination, other past companies also include sorted.com and the BBC. Richard served on the board of Seedcamp and was a non-Executive Director of Ladbrokes PLC between 2012 and 2016. In October 2016 Richard joined N Brown PLC as a Non-Executive Director. Richard has been featured in the ‘Wired 100’ and ‘Media Guardian 100’ lists, was named amongst the Telegraph Newspaper’s ‘1,000 Most Powerful People in British Business’, and was ranked in the Guardian Newspaper’s top 10 most influential people in digital media. Richard is also an Ernst & Young Entrepreneur of the Year, a member of the International Academy of Digital Arts and Sciences and the Young Presidents Organisation. Learn more about Richard Moross on Crunchbase…

Donna J. Barrett is President & CEO at Community Newspaper Holdings. She is Member of the Board of Directors at Associated Press. Learn more about Donna Barrett on Crunchbase…

Learn more about Mohammed Zulfiquar on Crunchbase…

Mr. Joseph Cosgrove, Chairman, President and CEO of Pentec Health has shepherded the firm through unprecedented periods of expansion, diversification of services and profitability. Under his management, Pentec, headquartered in suburban Philadelphia, has grown to become the largest privately held specialty infusion services company in the United States. Pentec Health is an industry leader having demonstrated competency as a provider of outsourced pharmacy services. The company has maintained an exemplary and high national profile in diversified and expanding healthcare segments. Currently, Pentec’s Renal division offers outsourced nutritional support products and services to hemodialysis providers; its’ Specialty Infusion division provides pain management services and products directly to patients, as an outsourced physician offering. Since joining Pentec in 2008, Mr. Cosgrove has overseen significant milestones including product launches, patent filings and the expansion of its physical plant and facilities. Also of major import, was his ability to negotiate and secure an investment by Northwest Equity Partners, thereby insuring the firm’s ability to capitalize on future growth opportunities. Under his leadership, Pentec has earned numerous distinctions: 2011-2015; Top 100 Best Places to Work in Pennsylvania; 2012 HR Department of the Year designation by Delaware Valley HR Awards, Inc.; 2012 Greater Philadelphia Alliance for Capital and Technology (PACT) Life Sciences Company of the Year; Joint Commission for Specialty Infusion and Renal Nutritional Home Care Services Gold Seal of Approval Accreditation, The Philadelphia 100® and Inc. Magazine 5000 lists of fastest-growing privately-held companies from 2009 through 2014. In 2015, both entities recognized Pentec’s consistent excellence: Philadelphia 100® awarded Pentec elite status via induction to its Hall of Fame and Inc. Magazine acknowledged the company for a 6th consecutive year. Mr. Cosgrove, professionally, was the recipient of the 2011 SmartCEO Circle of Excellence Award, the 2012 SmartCEO Future 50 Award and the 2012 Ernst & Young Entrepreneur of the Year Award. In 2015, he was honored as the recipient of the Philly 100 Founder’s Distinguished Achievement Award and was also inducted into Philly 100 CEO Hall of Fame Society. Additionally, Mr. Cosgrove received the 2015 National Kidney Foundation’s prestigious Leadership in Business Award. Mr. Cosgrove has more than 20 years of diversified life sciences industry experience. Prior to joining Pentec Health, he served as Vice President and General Manager for several operating units of Cardinal Health Inc. His early career was characterized by increasingly responsible executive roles at DuPont Pharmaceuticals Company and Neuman Health Services Inc. Mr. Cosgrove currently serves as a board member for Pentec Health, Incorporated, and the (NKF) National Kidney Foundation. His former board affiliations include, the National Home Infusion Association, Aerosol Science Laboratories, Inc and the Greater Philadelphia Chamber of Commerce (Member of Executive Committee and of the Diversity and Inclusion Committee.) Mr. Cosgrove holds a Bachelor of Science degree in business administration and marketing from Rowan University in Glassboro, NJ. Learn more about Joseph Cosgrove on Crunchbase…

Kieran Murphy is President and CEO of GE Healthcare, a $20 billion business unit of General Electric that provides transformational medical technologies and solutions to the global healthcare industry. GE Healthcare supports customers in over 100 countries with a broad range of services and systems, from diagnostic imaging and healthcare IT through to molecular diagnostics and life-sciences. Prior to this, Kieran was President and Chief Executive Officer of GE Healthcare Life Sciences, a $3.7 billion molecular medicine business that provides a broad range of industry-leading technologies and services for drug discovery, pre-clinical and clinical development and biopharmaceutical manufacturing, as well as molecular tools for diagnostics, therapy selection and treatment monitoring in patient care. Kieran was appointed CEO in May 2011 and oversaw significant revenue growth and geographic expansion of the molecular medicine business. Kieran joined GE Healthcare in 2008 from Whatman plc, a $230 million global supplier of filters and membranes for laboratory research, life sciences and medical diagnostic applications. Kieran has over twenty years’ experience in the global life sciences and biotechnology industry, beginning his career with Janssen Pharmaceutical, a division of Johnson and Johnson, followed by leadership roles with Mallinckrodt, veterinary medicines provider Vericore, Novartis, Adprotech, ML Laboratories and Innovata plc. Learn more about Kieran Murphy on Crunchbase…

John Murphy is President and CEO of WSP for Europe (including the UK), the Middle East, India, and Africa (EMEIA). John had joined Parsons Brinckerhoff in 2010 as Chief Financial Officer. John has more than 25 years of financial and senior management experience, including 14 years working with major engineering contractors and their domestic and international operations. Positions in this sector included serving as Executive Vice President and Finance Director for the Engineering & Consultancy Division of Kvaerner ASA in London, UK, and various roles in the US and Canada. John was CEO of Irving Transportation Services, with overall responsibility for the integrated transportation businesses of the Irving Group, one of the largest privately held conglomerates in Canada. John also served as the head of Irving Group’s Marine and Industrial Division. John received a Bachelor of Commerce degree from Mount Allison University in Canada and is a Canadian Chartered Accountant. Learn more about John Murphy on Crunchbase…

Real estate entrepreneur and manager, proptech expert with extensive knowledge of the impact of digital innovation on real estate. CEO of Donati Immobiliare Group, an international property developer, and co-founder of an innovative, London-based PropTech startup. After working at Goldman Sachs and Ralph Lauren, and with a degree from the London School of Economics and an MBA from Oxford University under her belt, she took on the challenge of the real estate industry, with the aim of building an international business. Learn more about Angelica Donati on Crunchbase…

Andrew Nelson has over 30 years experience in the semiconductor industry in a variety of research and managerial positions. Following a PhD in Semiconductor Physics, he joined BT Research Laboratories in 1981, leading the group responsible for the development of advanced optoelectronic devices for optical fibre communications. He subsequently managed the technology transfer from BT to Agilent for mass production. He co-founded EPI in 1988 (which became IQE in 1999) and was appointed Chief Executive Officer of IQE Plc in April 1999. Andrew has held several Non-Executive Directorship appointments, and served on several Government and Industry bodies. He received an OBE in 2001 for services to the Electronics Industry. He is currently a member of the High Level Group appointed by the EC to oversee the implementation of Key Enabling Technologies (KETs) throughout Europe. Learn more about Andrew Nelson on Crunchbase…

Mr. Dipankar Bhattacharjee was appointed President and CEO, Generics Europe in April 2013. Mr. Bhattacharjee joined Teva as Chief Executive Officer, Teva UK Limited in 2009. Prior to joining Teva, he served 15 years at Bausch + Lomb in various senior roles, including Vice President, Commercial in both Europe and Asia-Pacific regions, and Corporate Vice President and President, Asia Pacific Region. Mr. Bhattacharjee began his career at Nestlé SA and Bank of America. Mr. Bhattacharjee received a BA in Economics from St. Stephens College, University of Delhi, and a Masters degree in Management Studies from Jamnalal Bajaj Institute of Management Studies, University of Mumbai. ​​​​​​​​ Learn more about Dipankar Bhattacharjee on Crunchbase…

Dr. Toleikis is President and Chief Executive Officer of Sernova Corp since April 2009. From 2006 until 2009, Dr. Toleikis consulted for multiple device, combination product and pharmaceutical companies. From 1996 to 2006 he held multiple roles at Angiotech Pharmaceuticals, Inc. including Vice President, Research and Development – Pharmacology and Drug Screening where he built a product development team of over 50 scientists and was responsible for multiple corporate and academic product development collaborations. While at Sernova, Dr. Toleikis has secured over $60 million in various forms of financings, including equity raises and multiple non-dilutive grants and has been responsible for negotiating a worldwide exclusive license with UHN and University of Miami for its stem cell derived technologies as well as developing business relationships and or collaborations with multiple pharmaceutical and academic institutions involving its Cell Pouch™ device and cell technologies. Dr. Toleikis is an author of over 100 patent applications ande issued patents, and multiple scientific publications involving transplantation, metabolic, cardiovascular, oncology, and autoimmune disease. He obtained his Ph.D. in Medicine, Pharmacology and Therapeutics from the University of British Columbia, his M.Sc. at the University of Michigan and B.A. at the University of Vermont. Learn more about Philip M. Toleikis on Crunchbase…

Anne brings to Freeline over 25 years of experience in drug development and executive leadership across several therapeutic areas, with special focus on rare diseases and gene therapy. Anne most recently served as the CEO of Gyroscope Therapeutics, a preclinical gene therapy company focusing on ophthalmology, where she continues to serve as a non-executive Member of the Board. From 2014-2016, Anne was VP of Clinical Research Haematology and Global Therapeutic Area Head of Haematology in Baxalta, Boston, USA. In this role, she secured several new product approvals (US and EU). Before this, Anne held a number of senior leadership positions in a broad range of functional areas at Novo Nordisk, Denmark, leading global drug development programmes from research to commercialisation, and bringing several products to market globally. Anne has an MD from Copenhagen University and holds a PhD in Epidemiology. Learn more about Anne Prener on Crunchbase…

Carnegie and Rockefeller Professor and Head of Pharmacology at Dalhousie University; IWK Affiliated Scientist. He possesses expertise in molecular, genetic, and biochemical characterization of proteins focusing his work on the discovery and characterization of new lipid metabolizing enzymes and their regulators with an eye toward identifying new drug targets for the treatment of infectious disease, orphan diseases, and obesity. Chris is the recipient of several invited lectureships and numerous honors including Canadian Institutes of Health Research Fellowship and Scholarship awards, with these latter two awards ranked first in Canada. Learn more about Christopher McMaster on Crunchbase…

Allan Jones is President and Chief Executive Officer of the Allen Institute, an independent, nonprofit research organization dedicated to answering some of the biggest questions in bioscience and accelerating research worldwide. The Allen Institute currently encompasses three entities (the Allen Institute for Brain Science; the Allen Institute for Cell Science; and The Paul G. Allen Frontiers Group) supported by a shared administration group. Learn more about Allan Jones on Crunchbase…

Learn more about Adrian Lovett on Crunchbase…

Prior to joining World Travel & Tourism Council as President & CEO in November 2010, David worked for 6 years in private equity and venture capital, completing deals in technology and travel sectors. David was CEO of Opodo, pan-European online travel company from 2002 to 2004, building the business from start up to a €500mn transaction turnover, before it was sold to Amadeus. He joined the board of Hilton International in 1997 as senior VP sales, marketing and IT, leading the brand re-unification programme between the two Hilton shareholder companies. Learn more about David Scowsill on Crunchbase…

Founder of reportbrain Learn more about Alex D. Kostopoulos on Crunchbase…

Learn more about Deepa Bhate on Crunchbase…

Eddie Ahmed is the Chairman, President & CEO at MassMutual . Learn more about Eddie Ahmed on Crunchbase…